Biosimilars at the Forefront: Pioneering New Avenues in...
27 Mar 2024
Biosimilars, the close equivalents of biologic drugs with expired patents, are reshaping the landscape of the pharmaceutical industry. Their rise in popularity and demand is a multifaceted phenomenon, driven by economic, regulatory, and clinical fact...